Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: A cohort study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Dahab, Mison ^a,b,c   Charalambous, Salome ^b   Karstaedt, Alan S ^d   Fielding, Katherine L ^a   Hamilton, Robin ^b   La Grange, Lettie ^e   Churchyard, Gavin J ^a,b,c   Grant, Alison D ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b AURUM INSTITUTE   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e Anglo Platinum South Africa   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; FORECASTING; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; QUESTIONNAIRE; SOUTH AFRICA;

ADULT; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; FEMALE; FORECASTING; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; QUESTIONNAIRES; SOUTH AFRICA;

EID: 77954785319     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-430     Document Type: Article

References (51)

1. AIDS Epidemic Update. The Joint United Nations Programme on HIV/AIDS, Geneva: UNAIDS 2007
2. Towards Universal Access-Scaling up Priority HIV/AIDS Interventions in the Health Sector: Progress Report 2009. World Health Organization, the Joint United Nations Programme on HIV/AIDS, United Nations Children's Fund, Geneva: WHO 2009
3. Adherence is not a barrier to successful antiretroviral therapy in South Africa. C Orrell D Bangsberg M Badri R Wood, AIDS 2003 17 1369 1375 10.1097/00002030-200306130-00011 12799558
4. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. AL Gifford JE Bormann MJ Shively BC Wright DD Richman SA Bozzette, J Acquir Immune Defic Syndr 2000 23 386 395 10866231
5. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. RH Haubrich SJ Little JS Currier DN Forthal CA Kemper GN Beall D Johnson MP Dube JY Hwang JA McCutchan, AIDS 1999 13 1099 1107 10.1097/00002030-199906180-00014 10397541
6. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. I Laniece M Ciss A Desclaux K Diop F Mbodj B Ndiaye O Sylla E Delaporte I Ndoye, AIDS 2003 17 Suppl 3 103 108 10.1097/00002030-200317003- 00014 14565616
7. Virologic success rates drop off sharply with decreasing levels of adherence to antiretroviral therapy. V Montessori E Wood SL Beer, Proceedings of the XIIIth International AIDS Conference; Durban, South Africa 2000
8. Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use. A Palepu B Yip C Miller SA Strathdee MV O'Shaughnessy JS Montaner RS Hogg, AIDS 2001 15 423 424 10.1097/00002030-200102160-00021 11273228
9. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. E Mills J Nachega DR Bangsberg S Singh B Rachlis P Wu K Wilson I Buchan CJ Gill C Cooper, PLoS Med 2006 3 438 10.1371/journal.pmed.0030438 17121449
10. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. EJ Mills JB Nachega I Buchan J Orbinski A Attaran S Singh B Rachlis P Wu C Cooper L Thabane, et al. J Am Med Assoc 2006 296 679 690 10.1001/jama.296.6.679 (Pubitemid 44200639)
11. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. J Oyugi J Byakika-Tusiime K Ragland O Laeyendecker R Mugerwa C Kityo P Mugyenyi TC Quinn DR Bangsberg, AIDS 2007 21 965 971 10.1097/QAD.0b013e32802e6bfa 17457090
12. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. S Rosen MP Fox CJ Gill, PLoS Med 2007 4 298 10.1371/journal.pmed.0040298 17941716
13. Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Cte d'Ivoire. SP Eholié A Tanon S Polneau M Ouiminga A Djadji C Kangah-Koffi N Diakité X Anglaret A Kakou E Bissagnené J Acquir Immune Defic Syndr 2007 45 355 358 17438479
14. Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Z Iliyasu M Kabir IS Abubakar M Babashani ZA Zubair, Nigerian Journal of Medicine 2005 14 290 294 16350700
15. Low ART adherence in Africa. W Wakabi, Lancet Infect Dis 2008 8 94 10.1016/S1473-3099(08)70010-0 18300368
16. Inadequate adherence to antiretroviral treatment and prevention in hospital and community sites in Burkina Faso and Mali: a study by the ATARAO group. SA Aboubacrine P Niamba C Boileau MV Zunzunegui N Machouf VK Nguyen S Rashed, Int J STD AIDS 2007 18 741 747 10.1258/095646207782212243 18005507
17. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. S Weiser W Wolfe D Bangsberg I Thior P Gilbert J Makhema P Kebaabetswe D Dickenson K Mompati M Essex R Marklink, J Acquir Immune Defic Syndr 2003 34 281 288 10.1097/00126334-200311010-00004 14600572
18. Placebo practice trials: a tool to assess and improve adherence readiness. G Wagner M Iguchi S Schneider J Scott D Anderson, HIV Clin Trials 2002 3 475 481 10.1310/XGXU-FUDK-A9QT-MPTF 12501131
19. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. M Dahab S Charalambous R Hamilton K Fielding K Kielmann GJ Churchyard AD Grant, BMC Public Health 2008 18 63 10.1186/1471-2458-8-63 (Pubitemid 351467620)
20. Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. MC Marazzi G Liotta P Germano G Guidotti AD Altan S Ceffa MM Lio K Nielsen-Saines L Palombi, AIDS Res Hum Retroviruses 2008 24 555 560 10.1089/aid.2007.0217 18366314
21. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. SD Lawn AD Harries X Anglaret L Myer R Wood, AIDS 2008 22 1897 1908 10.1097/QAD.0b013e32830007cd 18784453
22. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. CG Victora SR Huttly SC Fuchs MT Olinto, Int J Epidemiol 1997 26 224 227 10.1093/ije/26.1.224 9126524
23. No room for complacency about adherence to antiretroviral therapy in sub-saharan Africa. CJ Gill DH Hamer JL Simon DM Thea LL Sabin, AIDS 2005 19 1243 1249 10.1097/01.aids.0000180094.04652.3b 16052078
24. Adherence without access to antiretroviral therapy in sub-saharan Africa? DR Bangsberg N Ware JM Simoni, AIDS 2006 20 140 141 10.1097/01.aids.0000196168. 50303.31 16327340
25. Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. CA Pinheiro JC de-Carvalho-Leite ML Drachler VL Silveira, Braz J Med Biol Res 2002 35 1173 1181 12424490
26. Effectiveness of antiretroviral therapy among patients who attend public HIV clinics in Rio de Janeiro, Brazil. CB Hofer M Schechter LH Harrison, J Acquir Immune Defic Syndr 2004 36 4 967 971 10.1097/00126334-200408010-00011 15220704
27. Factors associated with adherence to antiretroviral medication in HIV infected patients. A Molassiotis V Nahas-Lopez WY Chung SW Lam CK Li TF Lau, Int J STD AIDS 2002 13 301 310 10.1258/0956462021925117 11972933
28. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Cte d'Ivoire. S Diabaté M Alary CK Koffi, AIDS 2007 21 1799 1803 10.1097/QAD.0b013e3282a5667b 17690579
29. Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients. R Garcia R Badará EM Netto M Silva FS Amorin A Ramos F Vaida C Brites RT Schooley, AIDS Res Hum Retroviruses 2006 22 1248 1252 10.1089/aid.2006.22.1248 17209767
30. Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil. RH Remien FI Bastos VT Jnr JC Raxach RM Pinto RG Parker A Berkman MA Hacker, AIDS Care 2007 19 740 748 10.1080/09540120600842516 17573593
31. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. R Horne V Cooper G Gellaitry HL Date M Fisher, J Acquir Immune Defic Syndr 2007 45 334 341 17514019
32. Adherence to antiretroviral therapy: a qualitative study with physicians from Rio de Janeiro, Brazil. M Malta ML Petersen S Clair F Freitas FI Bastos, Cad Sade Pblica 2005 21 1424 1432 10.1590/S0102-311X2005000500015
33. Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. J Wanyama B Castelnuovo B Wandera P Mwebaze A Kambugu DR Bangsberg MR Kmya, AIDS 2007 21 1486 1487 10.1097/QAD.0b013e32823ecf7f 17589198
34. Traditional medicine-growing needs and potential. WHO Policy Perspectives on Medicines, no.2. World Health Organization, Geneva: WHO 2002 http://whqlibdoc.who.int/hq/2002/WHO-EDM-2002.4.pdf accessed 2 July 2008
35. Migrancy, masculine identities and AIDS: the psychosocial context of HIV transmission on the South African gold mines. C Campbell, Soc Sci Med 1997 45 2 273 281 10.1016/S0277-9536(96)00343-7 9225414
36. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. B Shah L Walshe DG Saple SH Mehta JP Ramónani RD Kharkar RC Bollinger A Gupta, Clin Infect Dis 2007 44 1235 1244 10.1086/513429 17407045
37. [Persons living with HIV/AIDS: factors associated with adherence to antiretroviral treatment]. EM Seidl A Melchiades V Farias A Brito, Cad Saude Publica 2007 23 2305 2316 10.1590/S0102-311X2007001000006 17891292
38. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. DE Bennett S Bertagnolio D Sutherland CF Gilks, Antivir Ther 2008 13 Suppl 2 1 13 18578063
39. Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006. G Maphalala V Okello S Mndzebele P Gwebu N Mulima S Dlamini B Nhlabatsi T Ginindza Y Ghebrenegus A Ntilivamunda, et al. Antivir Ther 2008 13 Suppl 2 95 100 18575197
40. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi. K Kamoto J Aberle-Grasse, Antivir Ther 2008 13 Suppl 2 83 87 18575195
41. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania. GR Somi T Kibuka K Diallo T Tuhuma DE Bennett C Yang C Kagoma EF Lyamuya RO Swai S Kassim, Antivir Ther 2008 13 Suppl 2 77 82 18575194
42. Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia. WE Abegaz Z Grossman D Wolday D Ram J Kaplan K Sibide T Wuhib S Ismael J Nkengasong T Mekonen, et al. Antivir Ther 2008 13 Suppl 2 89 94 18575196
43. HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam. HT Nguyen NB Duc R Shrivastava TH Tran TA Nguyen PH Thang JM McNicholl W Leelawiwat W Chonwattana K Sidibe, et al. Antivir Ther 2008 13 Suppl 2 115 121 18575200
44. Antiretroviral drug resistance surveillance among drug-nave HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004. V Pillay J Ledwaba G Hunt M Rakgotho B Singh L Makubalo DE Bennett A Puren L Morris, Antivir Ther 2008 13 Suppl 2 101 107 18575198
45. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). MA Chesney JR Ickovics DB Chambers AL Gifford J Neidig B Zwickl AW Wu, AIDS Care 2000 12 255 266 10.1080/09540120050042891 10928201
46. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. DR Bangsberg S Perry ED Charlebois RA Clark M Roberston AR Zolopa, AIDS 2001 15 1181 1183 10.1097/00002030-200106150-00015 11416722
47. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. DL Paterson S Swindells J Mohr M Brester EN Vergis C Squier MM Waener N Singh, Ann Intern Med 2000 133 21 30 10877736
48. Why do patients fail HIV therapy? L Waters M Nelson, Int J Clin Pract 2007 61 983 990 10.1111/j.1742-1241.2007.01383.x 17504360
49. Logistic Regression with STATA. X Chen P Ender M Mitchell C Wells, Los Angeles: University of California at Los Angeles 2008 http://www.ats.ucla.edu/ stat/stata/webbooks/logistic/ accessed 4 July 2008
50. BR Kirkwood JAC Sterne, Essential Medical Statistics Oxford: Blackwell Publishing 2 2003
51. DW Hosmer Jr S Lemishow, Applied Logistic Regression New York: John Wiley 2 2000